Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026
Screenshot preview · Scroll to view the full email
Archived for design inspiration. Original email and brand assets belong to their respective owners. Design observations describe the creative; they are not campaign results.
More emails like this
Explore other emails with shared design, campaign, or industry tags.
Novo NordiskView brand email archive
